Your browser doesn't support javascript.
loading
Plasma Concentrations of Pro-inflammatory Cytokine IL-6 and Antiinflammatory Cytokine IL-10 in Short- and Long-term Opioid Users with Noncancer Pain.
Mizher, Hussam; Zin, Che Suraya; Helal Uddin, Abul Bashar; Mohamed, Abdul Hadi; Ling, Tan H; Izzat, Munira.
Afiliación
  • Mizher H; Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia (IIUM), Kuantan, Pahang Darul Makmur, Malaysia.
  • Zin CS; Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia (IIUM), Kuantan, Pahang Darul Makmur, Malaysia.
  • Helal Uddin AB; Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia (IIUM), Kuantan, Pahang Darul Makmur, Malaysia.
  • Mohamed AH; Department of Anesthesiology and Intensive Care, Kulliyyah of Medicine, International Islamic University Malaysia (IIUM), Kuantan, Pahang Darul Makmur, Malaysia.
  • Ling TH; Department of Anesthesia and Intensive Care, Hospital Kuala Lumpur, Jalan Pahang, Federal Territory of Kuala Lumpur, Malaysia.
  • Izzat M; Department of Anesthesia and Intensive Care, Hospital Kuala Lumpur, Jalan Pahang, Federal Territory of Kuala Lumpur, Malaysia.
J Pharm Bioallied Sci ; 12(Suppl 2): S663-S666, 2020 Nov.
Article en En | MEDLINE | ID: mdl-33828357
INTRODUCTION: Little is known whether the duration of opioid use influences the concentrations of pro- and anti-inflammatory cytokines. OBJECTIVES: This study examined the plasma concentration of pro-inflammatory cytokine, interleukin 6 (IL-6), and anti-inflammatory cytokine, interleukin 10 (IL-10), in short-, and long-term opioid users with noncancer pain. MATERIALS AND METHODS: Adult patients with opioid therapy for noncancer pain were recruited from pain clinics at two tertiary hospital settings in Malaysia between February 2016 and March 2017. They were stratified into short- or long-term users based on opioid prescriptions ≥ 90 days per year. A 10mL blood sample was taken for the analysis of plasma concentrations of IL-6 and IL-10 and were quantified using a highly sensitive multiplex assay. RESULTS: Of 38 patients recruited, 24% (n = 9/38) and 76% (n = 29/38) were respectively short- and long-term opioid users. Short-term use of opioid was associated with higher levels of IL-6 (mean ± SD, 173.9 ± 13.7 pg/mL) and IL-10 (50 ± 5.8 pg/mL), whereas long-term use of opioids was associated with lower levels (no significant difference) of both cytokines IL6 (125 ± 16.1 pg/mL) and IL10 (41.3 ± 6.7 pg/mL). There was strong correlation between IL-6 and IL-10 within the same group (r² = 0.72, P < 0.05) and (r² = 0.76, P < 0.05) for short- and long-term users, respectively. CONCLUSION: The duration of opioid use may modulate the level of pro-inflammatory cytokines in which it was higher in short-term use and lower in long-term use, but the effect of pain relief was similar as both cytokines were well correlated.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pharm Bioallied Sci Año: 2020 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: India
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pharm Bioallied Sci Año: 2020 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: India